Stay updated on Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdministrative updates to the page metadata (revision v3.5.0 and EU trial identifier 2018-000096-32) were applied. There were no changes to the study details, eligibility criteria, or outcomes.SummaryDifference0.3%

- Check16 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 across the site.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.4.2 is shown, replacing v3.4.1, and the government funding notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check51 days agoChange DetectedAdditions include a government funding status notice and the new Revision: v3.4.1, while the previous Revision: v3.4.0 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check59 days agoChange DetectedAdded Show glossary and updated the study record for NCT03585465 with the EU CTIS number 2024-513470-22-00, status Actual, last QC update 2026-01-22, and Revision: v3.4.0; deprecated items such as IPD plans and older QC fields were removed.SummaryDifference0.8%

- Check73 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4 with no substantive changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.